Hypertension‐Mediated Organ Damage: Pathophysiological Mechanisms, Clinical Consequences, and Implications for Early Risk Stratification

Clinical and Experimental Pharmacology and Physiology · Published 2026-06-18 · DOI 10.1111/1440-1681.70142

Authors (1)

Ali Hussein Choker

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Choker, A. (2026). Hypertension‐Mediated Organ Damage: Pathophysiological Mechanisms, Clinical Consequences, and Implications for Early Risk Stratification. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70142

Related articles

• Apelin‐13 Attenuates Right Ventricular Hypertrophy and Pulmonary Fibrosis in a Monocrotaline Model of Pulmonary Hypertension · Clinical and Experimental Pharmacology and Physiology · 2025 · Same journal
• Effectiveness and Safety of Omalizumab in the Adjuvant Treatment of Patients With Refractory Acute Urticaria: A Real‐World Case–Control Study · Clinical and Experimental Pharmacology and Physiology · 2026 · Same journal
• Kaempferol Ameliorates Sepsis‐Acute Lung Injury by Promoting Succinylation of SRPK1 · Clinical and Experimental Pharmacology and Physiology · 2025 · Same journal
• Gemfibrozil Prevents Myocardial Ischemia–Reperfusion Injury in Mice Through AMPK Activation · Clinical and Experimental Pharmacology and Physiology · 2026 · Same journal
• Indole‐3‐Propionic Acid Improves Vascular Function in High‐Fat Diet‐Induced Obese Mice via eNOS · Clinical and Experimental Pharmacology and Physiology · 2025 · Same journal
• The TNF ‐α– FABP4 –Dhhc7 Axis Mediates Olanzapine‐Induced Insulin Resistance in Rats and Humans · Clinical and Experimental Pharmacology and Physiology · 2026 · Same journal
• The Health Education During Root Canal Therapy Reduces the Use of Antibiotics · Clinical and Experimental Pharmacology and Physiology · 2025 · Same journal
• METTL14 Inhibits Human Lung Microvascular Endothelial Cell From Ferroptosis in Septic Lung Injury by Regulating N 6 ‐Methyladenosine‐Modified ACSL4 Level · Clinical and Experimental Pharmacology and Physiology · 2025 · Same journal
• Inhibition of Bilirubin Generation Exacerbates Oxidative Stress and Liver Injury in Early‐to‐Intermediate Obstructive Cholestasis · Clinical and Experimental Pharmacology and Physiology · 2026 · Same journal
• Acepromazine Reduces Airway Contraction in a Murine Model of Asthma · Clinical and Experimental Pharmacology and Physiology · 2026 · Same journal